Quarterly pharmacy formulary change notice

Similar documents
Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

Quarterly pharmacy formulary change notice

3 Tier Formulary Additions

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Aetna Better Health of Illinois Medicaid Formulary Updates

QUANTITY LIMIT CRITERIA. BROVANA (arformoterol tartrate) SEREVENT DISKUS (salmeterol) STRIVERDI RESPIMAT (olodaterol)

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

Network Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary

Health Partners Medicare Prime 2019 Formulary Changes

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

Quarterly pharmacy formulary change

Step Therapy Requirements

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AETNA BETTER HEALTH January 2017 Formulary Change(s)

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

2018 CareOregon Advantage Part D Formulary Changes

Step Therapy Criteria

ACYCLOVIR OINT (CCHP2017)

Quarterly Pharmacy Formulary Change Notice

Date: October 3, 2017 To: Participating Providers From: YourCare Health Plan Provider Relations Subject: 2018 Formulary Changes

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

Emblem Medicaid 3Q18 Formulary Updates

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details.

Quarterly pharmacy formulary change notice

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Amerigroup Washington, Inc. to conduct postservice reviews of certain modifiers and services

Neighborhood Medicaid Formulary Changes: June 2017

Pharmacy Updates Summary

See Important Reminder at the end of this policy for important regulatory and legal information.

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

ANTIEMETICS STEP. Step Therapy Requirements Effective April 1, 2019

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

Calgary Long Term Care Formulary

WellCare s South Carolina Preferred Drug List Update

Kansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria

Calgary Long Term Care Formulary

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

Tribute 2018 Formulary 2018 Quantity Limit Criteria

Drug Class Monograph

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

EFFECTIVE 01/04/2019. pimecrolimus 1 % cream (g) - Added to Tier 1 - ST Added: TOPICAL IMMUNOMODULATORS

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.

2014 Quantity Limits (QL) Criteria

WVCH Formulary Additions Effective 01/01/2016 Name Strength Dosage Form Route Formulary Restrictions

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE

Updates to your prescription benefits

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

UPDATE Ohana QUEST Integration Medicaid

ELEVATE. Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard)

1, 2014 PHARMACY BENEFIT

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies

Clinical Policy: Dupilumab (Dupixent) Reference Number: ERX.SPA.49 Effective Date:

Clinical Policy: Roflumilast (Daliresp) Reference Number: CP.PMN.46 Effective Date: Last Review Date: 08.18

Tribute 2018 Formulary 2018 Quantity Limit Criteria

San Francisco Health Plan (SFHP)

Pharmacy Updates Summary

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016.

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

2019 Drug List Negative Changes

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

Step Therapy Requirements

Texas Vendor Drug Program. Formulary Drug Index File Layout. Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018

Texas Vendor Drug Program. Formulary Delimited File Layout. April 26, 2017

Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017

Oral Agents. Formulary Limits. Available Strengths. IR: 4mg ER: 12mg Syrup: 2mg/5ml

See Important Reminder at the end of this policy for important regulatory and legal information.

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

CARE N CARE HEALTH PLAN

Added, Removed or Changed. Date of Change. No Change

2018 Formulary Notice of Change Prescription Drug Plans

All Indiana Health Coverage Programs Pharmacy Providers

Quarterly pharmacy formulary change notice

Transcription:

Provider Bulletin October 2018 Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. The changes listed in the table below marked with an * also apply to all Anthem HealthKeepers Plus, Commonwealth Coordinated Care Plus (Anthem CCC Plus) patients. These changes were reviewed and approved at the second quarter Pharmacy and Therapeutics Committee meeting. Effective October 1, 2018, formulary changes, nonformulary changes and prior authorization requirements will apply. Therapeutic class DIABETIC SUPPLIES* DIABETIC SUPPLIES* HIV THERAPY * PROTON PUMP INHIBITORS (PPI) Effective for all Anthem HealthKeepers Plus patients on October 1, 2018 Medication BD PEN NEEDLES BD INSULIN SYRINGES ALL OTHER PEN NEEDLES AND INSULIN SYRINGES/MANUFACTURERS CIMDUO 300-300 MG TABLET SYMFI 600-300-300 MG TABLET TROGARZO 200 MG/1.33 ML VIAL BRAND PRILOSEC OTC 20 MG TABLET BRAND PRILOSEC OTC 20.6 MG TABLET BRAND OTC NEXIUM 24HR 20 MG CAPSULE EDITS Formulary status change NON- WITH STEP THERAPY (ST) COVERED Potential alternatives (preferred products) BD PEN NEEDLES BD INSULIN SYRINGES NO CHANGES IN /NON- STATUS REVISION OR ADDITION TO UM EDIT ONLY ADHD AGENTS METHYLPHENIDATE ER 72 MG TAB ADD QUANTITY LIMIT (QL) FRAGMIN 2,500 UNITS/0.2 ML SYR FRAGMIN 5,000 UNITS/0.2 ML SYR FRAGMIN 7,500 UNITS/0.3 ML SYR FRAGMIN 10,000 UNITS/ML SYR 6 ML (30 SYRINGES) PER 30 9 ML (30 SYRINGES) PER 30 30 ML (30 SYRINGES) PER 30 https://mediproviders.anthem.com/va HealthKeepers, Inc. is an independent licensee of the Blue Cross and Blue Shield Association. ANTHEM is a registered trademark of Anthem Insurance Companies, Inc. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Commonwealth Coordinated Care Plus (CCC Plus) benefits to enrollees. AVAPEC-1821-18 September 2018

Page 2 of 5 ANTIHYPERTENSIVES DRUGS* ANTIPARASITICS* ANTIPARASITICS* APPETITE STIMULATOR ASTHMA BOWEL PREP FRAGMIN 12,500 UNITS/0.5 ML FRAGMIN 15,000 UNITS/0.6 ML FRAGMIN 18,000 UNITS/0.72 ML FRAGMIN 25,000 UNITS/3.8 ML VL TEKTURNA 37.5MG ORAL PELLETS IMBRUVICA 140 MG CAPSULE IMBRUVICA 70 MG CAPSULE IMBRUVICA 140 MG TABLET ALBENZA 200 MG TABLET IMPAVIDO 50 MG CAPSULE MEGESTROL TABLET MEGESTROL ORAL SUSP BREO ELLIPTA 200-25 MCG INH BREO ELLIPTA 100-25 MCG INH FLUTICASONE-SALMETEROL 55-14 FLUTICASONE-SALMETEROL 113-14 FLUTICASONE-SALMETEROL 232-14 DULERA 100 MCG/5 MCG INHALER DULERA 200 MCG/5 MCG INHALER AIRDUO RESPICLICK 55-14 MCG AIRDUO RESPICLICK 113-14 MCG AIRDUO RESPICLICK 232-14 MCG ADVAIR 100-50 DISKUS ADVAIR 250-50 DISKUS ADVAIR 500-50 DISKUS ADVAIR HFA 115-21 MCG INHALER ADVAIR HFA 45-21 MCG INHALER ADVAIR HFA 230-21 MCG INHALER SYMBICORT 80-4.5 MCG INHALER SYMBICORT 160-4.5 MCG INHALER CLENPIQ SOLUTION BEXAROTENE 75 MG CAPSULE CABOMETYX 20 MG TABLET ZYKADIA 150 MG CAPSULE 15 ML (30 SYRINGES) PER 30 18 ML (30 SYRINGES) PER 30 22ML (30 SYRINGES) PER 30 22.8 ML (6 VIALS) PER 30 8 PELLETS PER DAY 4 CAPSULE PER DAY 84 CAPSULES PER FILL 1 FILL EVERY 30 PA REQUIRED REMOVING REQUIREMENT FOR ICS BEFORE ICS/LABA STEP THERAPY EFFECTIVE DATE 08.01.18 STEP THERAPY FOR T/F OF ICS/LABA STILL REQUIRED 320 MLS PER 30 10 CAPSULES PER DAY 3 CAPSULES PER DAY

CML* DERMATOLOGICAL AGENTS EPINEPHRINE AGENTS GLUCOSE ELEVATING PRESSURE PRESSURE PRESSURE AGENTS PRESSURE AGENTS TASIGNA 50 MG CAPSULE QUINJA 1.25%-1% GEL AUVI-Q 0.1 MG AUTO-INJECTOR GLUCAGEN 1 MG EMERGENCY KIT ULORIC 40 MG TABLET ULORIC 80 MG TABLET ZURAMPIC 200 MG TABLET KRYSTEXXA 8 MG/ML VIAL DEMSER 250 MG CAPSULE DIBENZYLINE 10 MG CAPSULE KAPSPARGO SPRINKLE PREXXARTAN Anthem HealthKeepers Plus Page 3 of 5 4 CAPSULES PER DAY 60 GMS PER 30 1 BOX (2 PENS) PER FILL 2 KITS IN 30 2 VIALS (2ML) PER 28 16 CAPSULES PER DAY 12 CAPSULES PER DAY 1 CAPSULE PER DAY 80 MLS PER DAY IBD STEROIDS UCERIS 2 MG RECTAL FOAM INTRANASAL STEROIDS MENOPAUSAL THERAPIES* MIGRAINE* AZOPT 1% EYE DROPS BETIMOL 0.25% EYE DROPS BETIMOL 0.5% EYE DROPS RHOPRESSA 0.02% OPHTH SOLUTION TIMOPTIC-XE 0.25% AND 0.5% EYE GEL-SOLN TIMOPTIC OCUMETER PLUS 0.25% AND 0.5 %GEL FORMING SOLN TIMOPTIC 0.25% AND 0.5% OCUDOSE DROP TIMOPTIC OCUMETER PLUS 0.25% AND 0.5% SOLN VYZULTA 0.024% OPHTH SOLUTION XHANCE 93 MCG NASAL SPRAY IMVEXXY 10 MCG VAGINAL INSERT IMVEXXY 4 MCG VAGINAL INSERT AIMOVIG 70 MG DOSE-2 AUTOINJ 15 MLS PER 30 15 MLS PER 30 1 BOTTLE PER 30 5 MLS PER 30 10 MLS PER 30 1 BOTTLE PER 30 2 INHALERS PER 30 18 VAGINAL INSERTS PER 28 1 AUTOINJECTOR/1 PACK PER 30

Page 4 of 5 MIGRAINE* GASTROINTESTINAL HEPATITIS B INTERFERON ANTIVIRAL THERAPY HEPATITIS B INTERFERON ANTIVIRAL THERAPY NEUROPATHIC PAIN AND FIBROMYALGIA NON-NARCOTIC ANALGESIC* NSAIDS PHOSPHATE BINDERS PRENATAL VITAMINS* PROGESTINS PROSTATE CANCER* PROSTATE CANCER* ANTIBACTERIALS ANTI- INFECTIVES* CORTICOSTEROIDS LOW POTENCY CORTICOSTEROIDS- VERY HIGH POTENCY AIMOVIG 140 MG DOSE-2 AUTOINJ SAMSCA 15 MG TABLET SAMSCA 30 MG TABLET RECTIV 0.4% OINTMENT PEGASYS (PEGINTERFERON ALFA 2A) INTRON A (INTERFERON ALFA 2B)* ZTLIDO FIORINAL 50-325-40 MG CAPSULE BUTALBITAL-ASA-CAFFEINE CAP BUTALB-ASPIRIN-CAFFE 50-325-40 CONSENSI CALCIUM ACETATE 668 MG TABLET NESTABS ONE SOFTGEL MAKENA 275 MG/1.1 ML AUTOINJCT ERLEADA 60 MG TABLET YONSA 125 MG TABLET ALTABAX 1% OINTMENT XEPI SYNALAR 0.025% OINTMENT KIT IMPOYZ 0.025% CREAM 2 AUTOINJECTORS/1 PACK PER 30 2 TABLETS PER DAY 30GM TUBE EVERY 30 REMOVE PA REQUIREMENTS REMOVE PA REQUIREMENTS 3 PATCHES PER DAY 6 TABLETS PER DAY 12 TABLETS PER DAY 4 AUTOINJECTORS PER 28 30GM PER FILL 1 FILL PER 30 45 GMS PER FILL 1 FILL PER 30 1 KIT PER 30 112 GM PER 30

Page 5 of 5 What action do I need to take? Please review these changes and work with your Anthem HealthKeepers Plus patients to transition them to formulary alternatives. If you determine formulary alternatives are not clinically appropriate for specific patients, you will need to obtain prior authorization to continue coverage beyond the applicable effective date. What if I need assistance? We recognize the unique aspects of patients cases. If your Anthem HealthKeepers Plus patient cannot be converted to a formulary alternative, call our Pharmacy department at 1-800-901-0020 (Anthem CCC Plus patients should call 1-855-322-4687) and follow the voice prompts for pharmacy prior authorization. You can find the Preferred Drug List (formulary) on our provider website at https://mediproviders.anthem.com/va. If you need assistance with any other item, contact your local Provider Relations representative or call Provider Services at 1-800-901-0020 (for Anthem CCC Plus assistance call 1-855-323-4687).